Menarini Asia-Pacific Holdings Pte Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Menarini Asia-Pacific Holdings Pte Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10590
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:シンガポール
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
A. Menarini Asia-Pacific Holdings Pte Ltd (A. Menarini Asia-Pacific), formerly Invida Group Pte Ltd, a subsidiary of A. Menarini Industrie Farmaceutiche Riunite Srl is a biopharmaceutical company that develops consumer health care products. The company operates through its divisions including R and D, biotech and diagnostics. Its R and D division access to global network of research and development infrastructure. A. Menarini Asia-Pacific’s biotech division develops and manufactures bio-pharmaceuticals, using mammalian cells and microbial production systems. The company’s diagnostics division provides technological solutions for healthcare professionals. It serves in the area of diabetes, autoimmunity, cell pathology, hemoglobin analysis, urine analysis, and others. A. Menarini Asia-Pacific is headquartered in Singapore.

Menarini Asia-Pacific Holdings Pte Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Menarini Asia-Pacific Holdings Pte Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Menarini Asia-Pacific Holdings Pte Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Menarini Asia-Pacific Holdings Pte Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Menarini Asia-Pacific Holdings Pte Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Menarini Asia-Pacific Holdings Pte Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Menarini Asia-Pacific Holdings Pte Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Menarini Asia-Pacific Holdings Pte Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Menarini Asia-Pacific Enters into Agreement with Merck 11
Moberg Pharma Extends Distribution Agreement With Menarini 12
Moberg Extends Distribution Agreement With Menarini For Kerasal Nail 13
Menarini Enters Into Commercialization Agreement With Gilead Sciences For Ranexa 14
Licensing Agreements 15
Menarini Enters into Licensing Agreement with Daiichi Sankyo 15
Menarini Enters into Licensing Agreement with Mitsubishi Tanabe Pharma for Spedra 16
Almirall Enters Into Licensing Agreement With Invida For Aclidinium 17
Faes Farma And Invida Enter Into Licensing Agreement For Bilastine 18
Menarini Asia-Pacific Holdings Pte Ltd – Key Competitors 19
Menarini Asia-Pacific Holdings Pte Ltd – Key Employees 20
Menarini Asia-Pacific Holdings Pte Ltd – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Menarini Asia-Pacific Holdings Pte Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Menarini Asia-Pacific Holdings Pte Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Menarini Asia-Pacific Holdings Pte Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Menarini Asia-Pacific Holdings Pte Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Menarini Asia-Pacific Holdings Pte Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Menarini Asia-Pacific Holdings Pte Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Menarini Asia-Pacific Holdings Pte Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Menarini Asia-Pacific Enters into Agreement with Merck 11
Moberg Pharma Extends Distribution Agreement With Menarini 12
Moberg Extends Distribution Agreement With Menarini For Kerasal Nail 13
Menarini Enters Into Commercialization Agreement With Gilead Sciences For Ranexa 14
Menarini Enters into Licensing Agreement with Daiichi Sankyo 15
Menarini Enters into Licensing Agreement with Mitsubishi Tanabe Pharma for Spedra 16
Almirall Enters Into Licensing Agreement With Invida For Aclidinium 17
Faes Farma And Invida Enter Into Licensing Agreement For Bilastine 18
Menarini Asia-Pacific Holdings Pte Ltd, Key Competitors 19
Menarini Asia-Pacific Holdings Pte Ltd, Key Employees 20
Menarini Asia-Pacific Holdings Pte Ltd, Subsidiaries 21

List of Figures
Menarini Asia-Pacific Holdings Pte Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Menarini Asia-Pacific Holdings Pte Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Menarini Asia-Pacific Holdings Pte Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Menarini Asia-Pacific Holdings Pte Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Menarini Asia-Pacific Holdings Pte Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Menarini Asia-Pacific Holdings Pte Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Menarini Asia-Pacific Holdings Pte Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Menarini Asia-Pacific Holdings Pte Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Menarini Asia-Pacific Holdings Pte Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Menarini Asia-Pacific Holdings Pte Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PDL BioPharma Inc (PDLI):医療機器:M&Aディール及び事業提携情報
    Summary PDL BioPharma Inc (PDL) formerly Protein Design Labs, Inc., manages a portfolio of patents and royalty assets that include Queen et al. patents and license agreements with various pharmaceutical and biotechnology companies, and royalty and other acquired assets. It offers financing solutions …
  • Mercer International Inc (MERC):企業の財務・戦略的SWOT分析
    Mercer International Inc (MERC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Toyo Tire Corp (5105):企業の財務・戦略的SWOT分析
    Toyo Tire Corp (5105) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Esab Holdings Ltd:企業の戦略・SWOT・財務分析
    Esab Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Esab Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • The Lubrizol Corp:企業の戦略的SWOT分析
    The Lubrizol Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Evgen Pharma Plc (EVG):製薬・医療:M&Aディール及び事業提携情報
    Summary Evgen Pharma Plc (Evgen Pharma), formerly Evgen Pharma Ltd is a clinical-stage drug development company that develops clinical pipeline for breast cancer and subarachnoid haemorrhage. The company develops SFX-01 to reduce the vasospasm and incidence of delayed cerebral ischemia which leads t …
  • Strata-X Energy Ltd (SXE):石油・ガス:M&Aディール及び事業提携情報
    Summary Strata-X Energy Ltd (Strata-X Energy), formerly Strata-X Ltd, is an independent oil and gas exploration company. The company operates in the acquisition, exploration and development of oil and gas properties in the US states of California and Illinois and in the Republic of Botswana. It prov …
  • TVEL Fuel Co:企業の戦略的SWOT分析
    TVEL Fuel Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • NorgesGruppen ASA:企業の戦略的SWOT分析
    NorgesGruppen ASA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Hydro One Ltd (H)-エネルギー分野:企業M&A・提携分析
    Summary Hydro One Limited (Hydro One) is a utility holding company that conducts electricity transmission and distribution, and telecom businesses in Ontario through its subsidiaries. The company serves residential, commercial and industrial customers. It serves large industrial customers through hi …
  • Industrial and Commercial Bank of China Ltd:戦略・SWOT・企業財務分析
    Industrial and Commercial Bank of China Ltd - Strategy, SWOT and Corporate Finance Report Summary Industrial and Commercial Bank of China Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Henry Schein, Inc.:企業のM&A・事業提携・投資動向
    Henry Schein, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Henry Schein, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Energy Transfer Partners LP (ETP):石油・ガス:M&Aディール及び事業提携情報
    Summary Energy Transfer Partners LP (ETP) is a master limited partnership. It owns and operates diversified portfolio of energy assets in the US. The partnership carries out the gathering, processing, storage, intra- and interstate transportation of natural gas and natural gas liquids. ETP also cond …
  • IVRCL Ltd:企業の戦略・SWOT・財務情報
    IVRCL Ltd - Strategy, SWOT and Corporate Finance Report Summary IVRCL Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Citizen Watch Co., Ltd. (7762):企業の財務・戦略的SWOT分析
    Citizen Watch Co., Ltd. (7762) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Kiadis Pharma NV (KDS):企業の財務・戦略的SWOT分析
    Summary Kiadis Pharma NV (Kiadis) is a biopharmaceutical company that develops and markets cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. The company offers cellular products including ATIR101 and ATIR201 for infusion. Its ATIR101 lowers the risks …
  • Bafna Pharmaceuticals Ltd (BAFNAPHARM):企業の財務・戦略的SWOT分析
    Summary Bafna Pharmaceuticals Ltd (Bafna Pharmaceuticals) is a pharmaceutical company that manufactures and markets medicinal products. The company provides operations such as domestic marketing, international marketing, international export and business development, among others. It offers products …
  • Stryker Corporation:企業のM&A・事業提携・投資動向
    Stryker Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Stryker Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Romelectro S.A.:企業の戦略的SWOT分析
    Romelectro S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • AVT McCormick Ingredients Pvt. Ltd.:企業の戦略・SWOT・財務情報
    AVT McCormick Ingredients Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report Summary AVT McCormick Ingredients Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆